Current role
Biotechnology · Healthcare
Board Member
2025-10-21–present
Dawn Carter Bir
Board Member
Filana Therapeutics, Inc. (FLNA)Equibles does not estimate personal net worth.
Get an email with a short summary when Filana Therapeutics, Inc. publishes a filing, an earnings call transcript or a press release.
Get FLNA alertsAbout Dawn Carter Bir
Dawn Carter Bir is recorded as Board Member at Filana Therapeutics, Inc. (FLNA) since October 21, 2025. Filana Therapeutics, Inc. reported in an 8-K filed October 22, 2025 that Dawn Carter Bir was appointed Class I director, effective October 21, 2025. Filana Therapeutics, Inc. is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at Filana Therapeutics, Inc. includes Richard (Rick) Barry (CEO), Richard J. Barry (CEO, Chairman and Board Member), Claude Nicaise (Chairman) and 7 others.
“On and effective October 21, 2025, the Board of Directors (“Board”) of Cassava Sciences, Inc. (the “Company”) expanded the size of the Board to eight members and appointed Dawn Carter Bir to the newly created Board seat.”
Affiliation history
-
Current
2025-10-21–present
Company network
Leadership on record at Filana Therapeutics, Inc.
- Richard (Rick) Barry CEO
- Richard J. Barry CEO, Chairman, Board Member
- Claude Nicaise Chairman
- Claude Nicaise, M.D. Chairman, Board Member
- Eric J. Schoen CFO
- R. Christopher Cook COO, General Counsel
- Dawn C. Bir Board Member
- Dr. Claude Nicaise Board Member
- Jill M. Quigley Board Member
- Michael J. O'Donnell Board Member